Identification of function for CD44 intracytoplasmic domain (CD44-ICD): Modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element

Journal of Biological Chemistry

Volumn 287, Issue 23, 2012, Pages 18995-19007

  Miletti González, Karl E ^a   Murphy, Kyle ^a   Kumaran, Muthu N ^a   Ravindranath, Abhilash K ^a   Wernyj, Roman P ^a   Kaur, Swayamjot ^a   Miles, Gregory D ^a   Lim, Elaine ^a   Chan, Rigel ^a   Chekmareva, Marina ^a   Heller, Debra S ^b   Foran, David ^a   Chen, Wenjin ^a   Reiss, Michael ^a   Bandera, Elisa V ^a   Scotto, Kathleen ^a   Rodríguez Rodríguez, Lorna ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELLS; CANCER STEM CELLS; CELL FUNCTIONS; COMPUTATIONAL ANALYSIS; CONSENSUS SEQUENCE; DNA CONSENSUS SEQUENCE; GENE ACTIVATION; GENES ENCODE; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATORY GENES; MATRIX METALLOPROTEINASE-9; MULTIFUNCTIONAL CELLS; NORMOXIC CONDITIONS; PROMOTER REGION; PROTEOLYTIC CLEAVAGE; RESPONSE ELEMENTS; SMALL MOLECULES; WARBURG EFFECTS;

CELL MEMBRANES; DISEASES; GENES; STEM CELLS;

TRANSCRIPTION;

DNA; GELATINASE B; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANAEROBIC GLYCOLYSIS; ARTICLE; CELL NUCLEUS; CELL TRANSPORT; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOPLASM; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; DOWN REGULATION; EARLY RESPONSE GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGENS, CD44; CELL NUCLEUS; FEMALE; GLYCOLYSIS; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASTIC STEM CELLS; PROTEIN STRUCTURE, TERTIARY; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

PYRONIA TITHONUS;

EID: 84861732970     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.318774     Document Type: Article

References (50)

1. Bourguignon, L. Y., Zhu, H., Chu, A., Iida, N., Zhang, L. & Hung, M. C. (1997) Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J. Biol. Chem. 272, 27913-27918 (Pubitemid 27473595)
2. Cannistra, S. A., Kansas, G. S., Niloff, J., DeFranzo, B., Kim, Y. & Ottensmeier, C. (1993) Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 53, 3830-3838 (Pubitemid 23252051)
3. Naor, D., Sionov, R. V.&Ish-Shalom, D. (1997) CD44. Structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241-319 (Pubitemid 27197761)
4. Hodge-Dufour, J., Noble, P. W., Horton, M. R., Bao, C., Wysoka, M., Burdick, M. D., Strieter, R. M., Trinchieri, G. & Puré, E. (1997) Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J. Immunol. 159, 2492-2500 (Pubitemid 127681045)
5. Zhao, L., Hall, J. A., Levenkova, N., Lee, E., Middleton, M. K., Zukas, A. M., Rader, D. J., Rux, J. J. & Puré, E. (2007) CD44 regulates vascular gene expression in a proatherogenic environment. Arterioscler. Thromb. Vasc. Biol. 27, 886-892 (Pubitemid 46606721)
6. Slomiany, M. G., Dai, L., Bomar, P. A., Knackstedt, T. J., Kranc, D. A., Tolliver, L., Maria, B. L.&Toole, B. P. (2009) Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res. 69, 4992-4998
7. Miletti-González, K. E. Chen, S., Muthukumaran, N., Saglimbeni, G. N., Wu, X., Yang, J., Apolito, K., Shih, W. J., Hait, W. N. & Rodríguez-Rodrgúez, L. (2005) The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 65, 6660-6667
8. Yasuda, M., Tanaka, Y., Fujii, K. & Yasumoto, K. (2001) CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int. Immunol. 13, 1309-1319 (Pubitemid 32994531)
9. Bajorath, J., Greenfield, B., Munro, S. B., Day, A. J. & Aruffo, A. (1998) Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol. Chem. 273, 338-343 (Pubitemid 28042214)
10. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U. & Bell, J. I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. U.S.A. 89, 12160-12164 (Pubitemid 23004805)
11. Spessotto, P., Rossi, F. M., Degan, M., Di Francia, R., Perris, R., Colombatti, A. & Gattei, V. (2002) Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J. Cell Biol. 158, 1133-1144
12. Takahashi, K., Eto, H. & Tanabe, K. K. (1999) Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int. J. Cancer 80, 387-395 (Pubitemid 29019625)
13. Zhang, Y., Thant, A. A., Machida, K., Ichigotani, Y., Naito, Y., Hiraiwa, Y., Senga, T., Sohara, Y., Matsuda, S. & Hamaguchi, M. (2002) Hyaluronan- CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res. 62, 3962-3965 (Pubitemid 34791060)
14. Okamoto, I., Kawano, Y., Murakami, D., Sasayama, T., Araki, N., Miki, T., Wong, A. J. & Saya, H. (2001) Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155, 755-762 (Pubitemid 34286228)
15. Gorden, D. L., Fingleton, B., Crawford, H. C., Jansen, D. E., Lepage, M. & Matrisian, L. M. (2007) Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. Int. J. Cancer 121, 495-500 (Pubitemid 46986480)
16. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M. & Shafie, S. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68 (Pubitemid 10098769)
17. Mori, H., Tomari, T., Koshikawa, N., Kajita, M., Itoh, Y., Sato, H., Tojo, H., Yana, I. & Seiki, M. (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 21, 3949-3959 (Pubitemid 34857428)
18. Yu, Q. & Stamenkovic, I. (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13, 35-48 (Pubitemid 29045114)
19. Alaniz, L., García, M., Cabrera, P., Arnaiz, M., Cavaliere, V., Blanco, G., Alvarez, E. & Hajos, S. (2004) Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-κB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem. Biophys. Res. Commun. 324, 736-743 (Pubitemid 39359194)
20. Clark, I. M., Swingler, T. E., Sampieri, C. L. & Edwards, D. R. (2008) The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40, 1362-1378
21. Muthukumaran, N., Miletti-González, K. E., Ravindranath, A. K. & Rodríguez-Rodríguez, L. (2006) Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells. Mol. Cancer Res. 4, 511-520 (Pubitemid 44341361)
22. Lammich, S., Okochi, M., Takeda, M., Kaether, C., Capell, A., Zimmer, A. K., Edbauer, D., Walter, J., Steiner, H. & Haass, C. (2002) Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J. Biol. Chem. 277, 44754-44759 (Pubitemid 36159067)
23. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T. & Selkoe, D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513-517
24. Pratap, J., Javed, A., Languino, L. R., van Wijnen, A. J., Stein, J. L., Stein, G. S. & Lian, J. B. (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25, 8581-8591 (Pubitemid 41369178)
25. Nowak, D. E., Tian, B. & Brasier, A. R. (2005) Two-step cross-linking method for identification of NF-≲καππα∀B gene network by chromatin immunoprecipitation. BioTechniques 39, 715-725
26. Zhang, L. S., Ma, H. W., Greyner, H. J., Zuo, W. & Mummert, M. E. (2010) Inhibition of cell proliferation by CD44. Akt is inactivated and EGR-1 is down-regulated. Cell. Prolif. 43, 385-395
27. Jinga, D. C., Blidaru, A., Condrea, I., Ardeleanu, C., Dragomir, C., Szegli, G., Stefanescu, M. & Matache C. (2006) MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer. Correlations with prognostic factors. J. Cell. Mol. Med. 10, 499-510 (Pubitemid 44872701)
28. Garbett, E. A., Reed, M. W., Stephenson, T. J. & Brown, N. J. (2000) Proteolysis in human breast cancer. Mol. Pathol. 53, 99-106 (Pubitemid 30183084)
29. Sinnamon, M. J., Carter, K. J., Fingleton, B. & Matrisian, L. M. (2008) Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int. J. Exp. Pathol. 89, 466-475
30. Tanimura, S., Asato, K., Fujishiro, S. H.&Kohno, M. (2003) Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: downregulation of matrix metalloproteinase-3/-9/-14 and CD44. Biochem. Biophys. Res. Commun. 304, 801-806 (Pubitemid 36513560)
31. Samanna, V., Ma, T., Mak, T. W., Rogers, M. & Chellaiah, M. A. (2007) Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. J. Cell. Physiol. 213, 710-720 (Pubitemid 350058264)
32. Yan, C. & Boyd, D. D. (2007) Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 211, 19-26 (Pubitemid 46363892)
33. Sugahara, K. N., Hirata, T., Hayasaka, H., Stern, R., Murai, T. & Miyasaka, M. (2006) Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J. Biol. Chem. 281, 5861-5868 (Pubitemid 43847686)
34. Sugahara, K. N., Murai, T., Nishinakamura, H., Kawashima, H., Saya, H. & Miyasaka, M. (2003) Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J. Biol. Chem. 278, 32259-32265 (Pubitemid 37048419)
35. Pelletier, L., Guillaumot, P., Frêche, B., Luquain, C., Christiansen, D., Brugière, S., Garin, J. & Manié, S. N. (2006) γ-Secretase-dependent proteolysis of CD44 promotes neoplastic transformation of rat fibroblastic cells. Cancer Res. 66, 3681-3687
36. Okamoto, I., Tsuiki, H., Kenyon, L. C., Godwin, A. K., Emlet, D. R., Holgado- Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T., Guha, A., Matsumoto, M., Ushio, Y., Saya, H. & Wong, A. J. (2002) Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am. J. Pathol. 160, 441-447 (Pubitemid 34160321)
37. Przybylowska, K., Zielinska, J., Zadrozny, M., Krawczyk, T., Kulig, A., Wozniak, P., Rykala, J., Kolacinska, A., Morawiec, Z., Drzewoski, J. & Blasiak, J. (2004) An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymph node metastasis in breast cancer. J. Exp. Clin. Cancer Res. 23, 121-125 (Pubitemid 38552606)
38. Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M. & García-Muñiz, J. L. (2007) Study of matrix metalloproteinases and their inhibitors in breast cancer. Br. J. Cancer 96, 903-911 (Pubitemid 46452295)
39. Stevens, J. W., Palechek, P. L., Griebling, T. L., Midura, R. J., Rokhlin, O. W. & Cohen, M. B. (1996) Expression of CD44 isoforms in human prostate tumor cell lines. Prostate 28, 153-161 (Pubitemid 26110735)
40. Tzircotis, G., Thorne, R. F. & Isacke, C. M. (2005) Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J. Cell Sci. 118, 5119-5128 (Pubitemid 41672442)
41. Bartrons, R. & Caro, J. (2007) Hypoxia, glucose metabolism and the Warburg's effect. J. Bioenerg. Biomembr. 39, 223-229 (Pubitemid 47619374)
42. Gatenby, R. A. & Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899 (Pubitemid 39472955)
43. Das, R. & Baker, D. (2008) Macromolecular modeling with rosetta. Annu. Rev. Biochem. 77, 363-382
44. Tamada, M., Nagano, O., Tateyama, S., Ohmura, M., Yae, T., Ishimoto, T., Sugihara, E., Onishi, N., Yamamoto, T., Yanagawa, H., Suematsu, M. & Saya, H. (2012) Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Res. 72, 1438-1448
45. Matou-Nasri, S., Gaffney, J., Kumar, S. & Slevin, M. (2009) Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signaling pathways involving Cdc2 and γ-adducin. Int. J. Oncol. 35, 761-773
46. Lakshman, M., Subramaniam, V. & Jothy, S. (2004) CD44 negatively regulates apoptosis in murine colonic epithelium via the mitochondrial pathway. Exp. Mol. Pathol. 76, 196-204 (Pubitemid 38569780)
47. Xie, Z., Choong, P. F., Poon, L. F., Zhou, J., Khng, J., Jasinghe, V. J., Palaniyandi, S. & Chen, C. S. (2008) Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion. Cancer Chemother. Pharmacol. 62, 949-957
48. Subramaniam, V., Vincent, I. R., Gardner, H., Chan, E., Dhamko, H. & Jothy, S. (2007) CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Exp. Mol. Pathol. 83, 207-215 (Pubitemid 47320661)
49. Abdraboh, M. E., Gaur, R. L., Hollenbach, A. D., Sandquist, D., Raj, M. H. & Ouhtit, A. (2011) Survivin is a novel target of CD44-promoted breast tumor invasion. Am. J. Pathol. 179, 555-563
50. Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325-337